Cellevate Inc.
Transforming Biomanufacturing Through Nanofiber Technology Cellevat3d® VAX microcarriers redefine viral vaccine production with >10-fold higher yields
Funding history
About Cellevate Inc.
How much funding has Cellevate Inc. raised?
Cellevate Inc. has raised $25K in total funding.
Where is Cellevate Inc. headquartered?
Cellevate Inc. is headquartered in Long Beach, CA.
What does Cellevate Inc. do?
Transforming Biomanufacturing Through Nanofiber Technology Cellevat3d® VAX microcarriers redefine viral vaccine production with >10-fold higher yields
What problem does Cellevate Inc. solve?
Conventional cell culture microcarriers limit yield and drive up cost and complexity in biopharmaceutical production of viral vaccines, vectors, and cell/gene therapies.
What's Cellevate Inc.'s solution?
Cellevate offers Cellevat3d, a proprietary nanofiber-based microcarrier technology for upstream bioprocessing that scales from R&D to commercial production.
What makes Cellevate Inc. different?
The company cites over 10-fold higher viral vaccine yields versus current solutions, up to 85% lower production costs, a biodegradable cellulose-based material, and ISO 9001:2015 certification with GMP clean-room manufacturing.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
